[Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells]

Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Jul;37(4):547-50.
[Article in Chinese]

Abstract

Objective: To evaluate the effects of selective and non-selective cyclooxygenase-2 on the growth and apoptosis of colon cancer cell lines in vitro.

Methods: The proliferation of colon cancer cells was determined by MTT assay, and the cell cycle progression was analyzed by flow cytometric assay. Annexin V/PI staining in combination with flow cytometric assay was used to detect apoptosis induced by NSAIDs.

Results: It was found that celecoxib, meloxicam and aspirin could inhibit the growth of HT-29 or SW480 cell and showed a concentration dependent pattern. COX-2 protein was expressed in HT-29 and LS174-T, but not in SW480 cells. In addition, PCNA levels in both HT-29 cell and SW480 cells were reduced by aspirin and celecoxib. Both aspirin (10 mmol/ L) and celecoxib (50 micromol/L) induced apoptosis of HT-29 and SW480 colon cancer cells, the apoptosis rates were 4.8%, 17.7% and 5.1%, 20.4% respectively.

Conclusion: Both COX-2 selective and non-selective inhibitors can potentially inhibit the growth of colon cell lines and such inhibitory effect on COX-2 negative colon cancer cells is also evident.

MeSH terms

  • Apoptosis / drug effects*
  • Aspirin / pharmacology
  • Celecoxib
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Colonic Neoplasms / pathology*
  • Cyclooxygenase 2 Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Meloxicam
  • Pyrazoles / pharmacology
  • Sulfonamides / pharmacology
  • Thiazines / pharmacology
  • Thiazoles / pharmacology

Substances

  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Thiazines
  • Thiazoles
  • Celecoxib
  • Aspirin
  • Meloxicam